COHN vs JPM
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
COHN presents a classic deep-value opportunity with a Piotroski F-Score of 4/9 indicating stable financial health and a current price ($21.88) trading significantly below both its Graham Number ($53.43) and Intrinsic Value ($30.45). The company exhibits explosive revenue growth (493.40% YoY) and an exceptional ROE of 41.51%, though these are offset by high leverage (Debt/Equity 4.41). While technical trends and insider sentiment are currently bearish, the fundamental valuation gap and profitability metrics suggest significant upside potential.
JPM exhibits a concerning Piotroski F-Score of 2/9, indicating weak short-term fundamental health, and currently trades at a significant premium to both its Graham Number ($239.11) and Intrinsic Value ($140.07). While the company maintains a strong ROE of 16.13% and dominant market positioning, negative YoY earnings growth (-3.60%) and bearish insider activity from the CEO and CFO signal internal caution. The stock's current price of $313.68 suggests the market is pricing in a growth premium that is not currently supported by the deterministic health or value metrics.
Compare Another Pair
Related Comparisons
COHN vs JPM: Head-to-Head Comparison
This page compares Cohen & Company Inc. (COHN) and JPMorgan Chase & Co. (JPM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.